Integrative Genetic and Functional Analysis Identifies the Asparagine–SLC38A2 Axis in Esophageal Squamous Cell Carcinoma
Molecular Carcinogenesis · 01.11.2026
DOI: 10.1002/mc.70201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 01.11.2026. Verfasst von Jialing Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Toxicology, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of S…. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Metabolic reprogramming is a hallmark of cancer, yet the relationships between specific circulating metabolites and esophageal squamous cell carcinoma (ESCC) remain unclear. This study aimed to investigate circulating metabolites potentially associated with ESCC risk and explore their biological relevance through an integrative approach. We employed two‐sample Mendelian randomization (MR) integrating genome‐wide association data from Japanese population, followed by multi‐omics profiling, single‐cell transcriptomic analysis, and in vitro functional validation. MR analyses provided suggestive evidence supporting a potential association between genetically proxied circulating asparagine levels and increased ESCC risk. Asparagine biosynthetic enzymes were enriched in proliferative epithelial cells, while the transporter SLC38A2 was upregulated in invasive epithelial cells and cancer‐associated fibroblasts (CAFs), and was associated with transcriptional programs related to epithelial‐to‐mesenchymal transition, immunosuppression, and extracellular matrix remodeling. Notably, SLC38A2 overexpression in tumor tissues was associated with worse overall survival. Functional assays showed that exogenous asparagine increased SLC38A2 expression and promoted ESCC cell proliferation, invasion, and CAF migration. Collectively, these findings provide convergent genetic, transcriptomic, and functional evidence implicating the asparagine–SLC38A2 axis in ESCC biology. SLC38A2 may represent a mechanistically relevant metabolic vulnerability that warrants further preclinical investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Toxicology, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Cancer Research Institute, Xinjiang Key Laboratory of Translational Biomedical Engineering, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, P. R. China.
ORCID-Profile: Jialing Ma, Wenjia Guo, Jiang Chang
Förderung
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Ma, J., Wu, Y., Luo, Y., Feng, J., Guo, W., & Chang, J. (2026). Integrative Genetic and Functional Analysis Identifies the Asparagine–SLC38A2 Axis in Esophageal Squamous Cell Carcinoma. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70201
Vancouver
Ma J, Wu Y, Luo Y, Feng J, Guo W, Chang J. Integrative Genetic and Functional Analysis Identifies the Asparagine–SLC38A2 Axis in Esophageal Squamous Cell Carcinoma. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70201
BibTeX
@article{Ma2026,
author = {Ma, Jialing and Wu, Yutong and Luo, Yintong and Feng, Jingwei and Guo, Wenjia and Chang, Jiang},
title = {Integrative Genetic and Functional Analysis Identifies the Asparagine–SLC38A2 Axis in Esophageal Squamous Cell Carcinoma},
journal = {Molecular Carcinogenesis},
year = {2026},
doi = {10.1002/mc.70201}
}
EUVIMED